Hemorrhage after Ischemic Stroke – Relation to Age and Previous Hemorrhage in a Nationwide Cohort of 58 868 Patients

Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs

(2010) Joachim Röther et al.   CEREBROVASCULAR DISEASES

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

The Riks-Stroke Story: Building a Sustainable National Register for Quality Assessment of Stroke Care

(2010) Kjell Asplund et al.   International Journal of Stroke

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Carotid stenting: more risky than endarterectomy and often no better than medical treatment alone

(2010) Peter M Rothwell   LANCET

Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events

(2010) Graeme J Hankey et al.   LANCET NEUROLOGY

Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients

(2010) W. Feng et al.   NEUROLOGY

Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke

(2010) Eva-Lotta Glader et al.   STROKE

Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?

(2009) M. Haris U. Usman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

(2008) Sam Schulman et al.   CHEST